Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-28T07:54:06.885Z Has data issue: false hasContentIssue false

A modified HET–CAM approach for biocompatibility testing of medical devices

Published online by Cambridge University Press:  11 January 2023

C Eder*
Affiliation:
Department of Orthopaedic Surgery, Medical University Vienna, Austria zet — Centre for Alternative and Complementary Methods to Animal Testing, Linz, Austria
E Falkner
Affiliation:
zet — Centre for Alternative and Complementary Methods to Animal Testing, Linz, Austria Core Unit for Biomedical Research, Medical University Vienna, Austria
M Mickel
Affiliation:
Karl Landsteiner Institute for Applied Cardiovascular Research, Vienna, Austria
C Chiari-Grisar
Affiliation:
Department of Orthopaedic Surgery, Medical University Vienna, Austria
H Appl
Affiliation:
zet — Centre for Alternative and Complementary Methods to Animal Testing, Linz, Austria
H Schöffl
Affiliation:
zet — Centre for Alternative and Complementary Methods to Animal Testing, Linz, Austria
S Nehrer
Affiliation:
Department of Orthopaedic Surgery, Medical University Vienna, Austria
UM Losert
Affiliation:
Core Unit for Biomedical Research, Medical University Vienna, Austria
*
* Contact for correspondence and requests for reprints: eder@zet.or.at

Abstract

The implantation of new biomedical devices into living animals without any previous toxicity or biocompatibility evaluation is possible under current legislation. The HET–CAM (Hen Egg Test–Chorionallantoic Membrane) test offers a partially immunodeficient, borderline in vitro/in vivo test system that allows the simulation of transplantation experiments to obtain biocompatibility data prior to animal testing. A collagen type I/III scaffold, designed for tissue regeneration, was tested for angiogenetic properties and biocompatibility patterns. A significant angiogenetic stimulus caused by the collagen scaffold material was observed. Altering biocompatibility patterns by incubation with the potentially hazardous chemicals acridine orange and ethidium bromide led to severe vessel thrombosis and a foreign body tissue response. CAM testing of biomaterials and tissue engineered products allows selection of the most suitable biomaterial and the elimination of unsuitable materials from animal experiments, leading to a refinement of testing procedures and a reduction in the number of animals required for biocompatibility testing.

Type
Research Article
Copyright
© 2005 Universities Federation for Animal Welfare

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Austrian Federal Law 1989 Regulating experimental procedures on living animals, 27 September 1989. http://www.bmbwk.gv.at/forschung/recht/tierversuche/tvg.xml (accessed 20 September 2005)Google Scholar
Bohnsack, U 2003 DIN EN ISO 10993–1. In: DIN (Deutsches Institut für Normung [German Institute for Standardization]) (ed) Medizinprodukte in Europa Rechtsetzung und Normung: [Title translation: Medicine Products in Europe Law-making and Standardization]. ISBN 3 410 14034 4Google Scholar
Borges, J, Tegtmeier, FT, Padron, NT, Mueller, MC, Lang, EM and Stark, GB 2003 Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Engineering 9(3): 441450CrossRefGoogle ScholarPubMed
Briscoe, DM, Dharnidharka, VR, Isaacs, C, Downing, G, Prosky, S, Shaw, P, Parenteau, NL and Hardin-Young, J 1999 The allogeneic response to cultured human skin equivalent in the hu–PBL–SCID mouse model of skin rejection. Transplantation 67(12): 19501959CrossRefGoogle ScholarPubMed
Davies JE (ed) 2000 Bone Engineering. Em Squared Inc: Toronto, CanadaGoogle Scholar
Djabari, Z, Bauza, E, Dal Farra, C and Domloge, N 2002 The HET–CAM test combined with histological studies for better evaluation of active ingredient innocuity. International Journal of Tissue Reactions — Experimental and Clinical Aspects 24(4): 117121Google ScholarPubMed
Falkner, E, Eder, C, Kapeller, B, Fröschl, W, Schmatz, C, Macfelda, K and Losert, UM 2004 The mandatory CAM testing of cells and scaffolds for tissue engineering: benefits for the 3Rs of cooperation with the vaccine industry. ATLA 32: 573580Google Scholar
Fukuda, K 2001 Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artificial Organs 25(3): 187193CrossRefGoogle ScholarPubMed
Hamburger, V and Hamilton, L 1992 A series of normal stages in the development of the chick embryo. Developmental Dynamics 195: 231272CrossRefGoogle ScholarPubMed
Jux, C, Wohlsein, P, Bruegmann, M, Zutz, M, Franzbach, B and Bertram, H 2003 A new biological matrix for septal occlusion. Journal of Interventional Cardiology 6(2): 149152CrossRefGoogle Scholar
Kalteis, T, Luring, C, Gugler, G, Zysk, S, Caro, W, Handel, M and Grifka, J 2004 Acute tissue toxicity of PMMA bone cements. Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete 142(6): 666672CrossRefGoogle ScholarPubMed
Kalweit, S, Gerner, I and Spielmann, H 1987 Validation project of alternatives for the Draize eye test. Molecular Toxicology 1(4): 597603Google ScholarPubMed
Ochi, M, Uchio, Y, Tobita, M and Kuriwaka, M 2001 Current concepts in tissue engineering technique for repair of cartilage defect. Artificial Organs 25(3): 172179CrossRefGoogle ScholarPubMed
Romeis, B 1989 Mikroskopische Technik. Urban & Schwarzenberg: Munich, Germany [Title translation: Microscopic Technology]Google Scholar
Russel, WMS and Burch, RL 1959 (reprinted 1992) The Principles of Humane Experimental Technique. Universities Federation for Animal Welfare: Wheathampstead, UK http://www.forschung3r.ch/de/publications/bu7.html (accessed 3 February 2005)Google Scholar
Spielmann, H 1995 HET–CAM test. Methods in Molecular Biology 43: 199204Google ScholarPubMed
van Tienhoven, EAE, Geertsma, RE, Wassenaar, C and de Jong, WH 2001 Pre-clinical safety assessment of Tissue Engineered Medical Products (TEMPs) — an investigation on assays and guidelines for biocompatibility testing. RIVM report 640080 002/2001. http://www.rivm.nl/bibliotheek/rapporten/640080002.pdf (accessed 16 September 2005)Google Scholar